Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

Well they may update this every couple of years but they are still missing these useful specific stroke prevention tips like 11 Stroke risk reduction ideas.
I don't think a single person here thinks outside the box and thus misses actions that are more likely to be implemented. But I should never criticize the medical gods.
http://stroke.ahajournals.org/content/42/1/227.full

A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

1. Karen L. Furie, MD, MPH, FAHA, Chair;
2. Scott E. Kasner, MD, MSCE, FAHA, Vice Chair;
3. Robert J. Adams, MD, MS, FAHA;
4. Gregory W. Albers, MD;
5. Ruth L. Bush, MD, MPH;
6. Susan C. Fagan, PharmD, FAHA;
7. Jonathan L. Halperin, MD, FAHA;
8. S. Claiborne Johnston, MD, PhD;
9. Irene Katzan, MD, MS, FAHA;
10. Walter N. Kernan, MD;
11. Pamela H. Mitchell, PhD, CNRN, RN, FAAN, FAHA;
12. Bruce Ovbiagele, MD, MS, FAHA;
13. Yuko Y. Palesch, PhD;
14. Ralph L. Sacco, MD, MS, FAHA, FAAN;
15. Lee H. Schwamm, MD, FAHA;
16. Sylvia Wassertheil-Smoller, MD, PhD, FAHA;
17. Tanya N. Turan, MD, FAHA;
18. Deidre Wentworth, MSN, RN
19. on behalf of the American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research

 

Next Section

Abstract

The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or transient ischemic attack. Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke. Further recommendations are provided for the prevention of recurrent stroke in a variety of other specific circumstances, including arterial dissections; patent foramen ovale; hyperhomocysteinemia; hypercoagulable states; sickle cell disease; cerebral venous sinus thrombosis; stroke among women, particularly with regard to pregnancy and the use of postmenopausal hormones; the use of anticoagulation after cerebral hemorrhage; and special approaches to the implementation of guidelines and their use in high-risk populations.

Stroke is a major source of mortality and morbidity in the United States. Survivors of a transient ischemic attack (TIA) or stroke represent a population at increased risk of subsequent stroke. Approximately one quarter of the 795 000 strokes that occur each year are recurrent events. The true prevalence of TIA is difficult to gauge because a large proportion of patients who experience a TIA fail to report it to a healthcare provider.¹ On the basis of epidemiological data defining the determinants of recurrent stroke and the results of clinical trials, it is possible to derive evidence-based recommendations to reduce stroke risk. Notably, much of the existing data come from studies with limited numbers of older adults, women, and diverse ethnic groups, and additional research is needed to confirm the generalizability of the published findings.

The aim of this statement is to provide clinicians with the most up-to-date evidence-based recommendations for the prevention of ischemic stroke among survivors of ischemic stroke or TIA.